LSTM Home > LSTM Research > LSTM Online Archive

Ebola virus disease

Downloads

Downloads per month over past year

Jacob, Shevin ORCID: https://orcid.org/0000-0003-2425-9394, Crozier, Ian, Fischer, William A., Hewlett, Angela, Kraft, Colleen S., Vega, Marc-Antoine de La, Soka, Moses J., Wahl, Victoria, Griffiths, Anthony, Bollinger, Laura and Kuhn, Jens H. (2020) 'Ebola virus disease'. Nature Reviews Disease Primers, Vol 6, e13.

[img] Text
SJ EBOLA ACCEPTED.docx - Accepted Version
Restricted to Repository staff only until 20 August 2020.

Download (949kB)

Abstract

Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission, followed by human-to-human transmission via direct contact or contact with infected bodily fluids or contaminated fomites. EVD has a high case–fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome. Diagnosis requires a combination of case definition and laboratory tests, typically real-time reverse transcription PCR to detect viral RNA or rapid diagnostic tests based on immunoassays to detect EBOV antigens. Recent advances in medical countermeasure research resulted in the recent approval of an EBOV-targeted vaccine by European and US regulatory agencies. The results of a randomized clinical trial of investigational therapeutics for EVD demonstrated survival benefits from two monoclonal antibody products targeting the EBOV membrane glycoprotein. New observations emerging from the unprecedented 2013–2016 Western African EVD outbreak (the largest in history) and the ongoing EVD outbreak in the Democratic Republic of the Congo have substantially improved the understanding of EVD and viral persistence in survivors of EVD, resulting in new strategies toward prevention of infection and optimization of clinical management, acute illness outcomes and attendance to the clinical care needs of patients.

Item Type: Article
Subjects: QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 805 Vaccines. Antitoxins. Toxoids
WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases
WA Public Health > Preventive Medicine > WA 115 Immunization
WC Communicable Diseases > Virus Diseases > Viral Hemorrhagic Fevers. Other Virus Diseases > WC 534 Viral hemorrhagic fevers
WC Communicable Diseases > Tropical and Parasitic Diseases > WC 950 Zoonoses (General)
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI): https://doi.org/10.1038/s41572-020-0147-3
Depositing User: Marie Hatton
Date Deposited: 25 Feb 2020 09:55
Last Modified: 27 Feb 2020 16:49
URI: https://archive.lstmed.ac.uk/id/eprint/13799

Statistics

View details

Actions (login required)

Edit Item Edit Item